My questions is if Phase III Clinical Trials could be undertaken without having the Phase I and II clinical studies done ? The drug under discussion is an already existing product in the market.
Could studies like pharmacokinetics and pharmacodynamics be done as substitute of Phase I and II ?
Could studies like pharmacokinetics and pharmacodynamics be done as substitute of Phase I and II ?